2009年　欧文

Ikeda M, Kawarabayashi T, Harigaya Y, Sasaki A, Yamada S, Matsubara E, Murakami T, Tanaka Y, Kurata T, Wuhua X, Ueda K, Kuribara H, Ikarashi Y, Nakazato Y, Okamoto K, Abe K, Shoji M (2009) Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology. Brain Res 1250; 232-241

Ishibashi S, Yamazaki T, Okamoto K (2009) Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C. J Clin Neurosci 16: 954-959

Kadokura A, Yamazaki T, Kakuda S, Lemewre CA, Fujita Y, Takatama M, Okamoto K (2009) Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration. Neurosci Lett 463; 87-92

Kadokura A, Yamazaki T, Lemewre CA,Takatama M, Okamoto K (2009) Regional distribution of TDP-43 inclusions in Alzheimer Disease (AD) brain: their relationship to AD common pathology. Neuropathology 29:; 566-573

Makioka K, Yamazaki T, Okamoto K (2009) Variations in the effects on synthesis of amyloid beta protein in modulated autophagic conditions. Neurological Res 31; 959-968

Mizuno Y, Guyon JR, Okamoto K, Kunkel LM (2009) Expression of synemin in the mouse spinal cord. Muscle Nerve 39; 634-641

Ono K, Ikemoto M, Kawarabayashi T, Ikeda M, Nishinakagawa T, Hosokawa M, Shoji M, Takahashi M, Nakashima M (2009) A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P+A53T transgenic mice. Parkinsonism Relat Disord 15; 649-654

Yanagida K, Okochi M, Tagami S, Nakayama T, Kodama TS, Nishitomi K, Jiang J, Mori K, Tatsumi S, Arai T, Ikeuchi T, Kasuga K, Tokuda T, Kondo M, Ikeda M, Deguchi K, Kazui H, Tanaka T, Morihara T, Hashimoto R, Kudo T, Steiner H, Haass C, Tsuchiya K, Akiyama H, Kuwano R, Takeda M (2009) The 28-amino acid form of an APLP1-derived Abeta-like peptide is a surrogate marker for Abeta42 production in the central nervous system. EMBO Mol Med 4; 223-235